Clinical Trial

A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 17, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A phase Ⅰ clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of GEN-725 tablets in patients with advanced solid tumors.
Trial Details
NCT Number NCT07229898
Lead Sponsor Henan Genuine Biotech Co., Ltd.
Conditions Advanced Solid Tumors
Enrollment 48 participants
Start Date 2025-01-07
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-17